相关实验视频

Updated: Jan 14, 2026

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

通过SMYD2介导的STAT1甲基化,通过阻断JAK-STAT1信号通路,保护肝脏缺血/反损伤

Zhiyong Yang¹, Yufeng Hu¹, Chunyong Yang¹

¹Department of Anesthesiology, Southwest Hospital, Third Military Medical University, Chongqing; State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China.

|October 17, 2025

概括

含有2 (SMYD2) 的SET和MYND域通过甲基化在肝脏缺血/再输液 (I/R) 损伤中负面调节信号传感器和转录1 (STAT1) 的激活器. 针对这种SMYD2-STAT1轴可能为肝损伤提供新的治疗策略.

科学领域:

肝病学肝病学是一种肝病学.
分子生物学分子生物学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

肝脏缺血/再输 (I/R) 损伤是一个重要的外科手术后并发症.
信号传感器和转录1 (STAT1) 激活器激活会加剧I/R损伤.
在肝脏I/R中,STAT1的特定翻译后修改 (PTM) 尚不清楚.

研究的目的:

确定肝脏I/R损伤中STAT1的新型调节剂.
研究SET和MYND域含有2 (SMYD2) 在肝脏I/R期间STAT1调制中的作用.
在STAT1.1上阐明SMYD2介导的PTM的机制基础.

主要方法:

综合转录基因-蛋白基因分析和功能查确定了SMYD2.
SMYD2表达与术后肝功能之间的临床相关性.
在体外和体外的功能丧失和功能获取研究验证了SMYD2的作用.

主要成果:

SMYD2通过JAK-STAT1通路调节肝脏I/R损伤.
增加SMYD2表达与改善肝功能和手术结果相关.
SMYD2在K175处甲基化STAT1,抑制其酸化和核转位,从而减轻I/R损伤.

结论:

SMYD2通过K175甲基化作为STAT1的新型负调节剂.
这项研究揭示了一种表观遗传机制,可以控制肝脏I/R中的STAT1信号传递.
针对SMYD2-STAT1轴为I/R相关的肝损伤提供了潜在的治疗策略.

关键词:

严重的肝脏衰竭肝脏手术肝脏手术缺血 - 复 perfusion 的情况.甲基化甲基化甲基化

更多相关视频

Use of a Hanging-weight System for Liver Ischemia in Mice

Use of a Hanging-weight System for Liver Ischemia in Mice

Published on: August 7, 2012

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...